Spots Global Cancer Trial Database for hippo pathway
Every month we try and update this database with for hippo pathway cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer | NCT03358017 | Triple Negative... | Zoledronate Atorvastatin 80... Standard neoadj... | 18 Years - | Mario Negri Institute for Pharmacological Research | |
Targeting the Hippo Transducer TAZ in Breast Cancer With Statins | NCT02416427 | Breast Neoplasm... | Atorvastatin | 18 Years - 75 Years | Regina Elena Cancer Institute | |
Targeting the Hippo Transducer TAZ in Breast Cancer With Statins | NCT02416427 | Breast Neoplasm... | Atorvastatin | 18 Years - 75 Years | Regina Elena Cancer Institute |